Cancer research reveals blood tests can detect tumor-derived mutations years before diagnosis. Johns Hopkins scientists ...

American researchers from Johns Hopkins University discovered that genetic material shed from tumors can be identified in the ...

Shield is the first FDA-approved blood test for primary colorectal ... that would use blood samples to detect colorectal cancers. The device detects a colon cancer secreted protein known as ...

A blood-based test has acceptable accuracy for colorectal cancer detection but not for advanced precancerous lesions in an ...

Madison-based Exact Sciences' story illustrates that basic research — combined with hard work, strong teams and enough money ...

Let’s make June a turning point where more people get screened, more cancers are caught early and fewer lives are lost.

Freenome plans to complete all modules of its premarket approval submission in mid-2025.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer (CRC) screening has been named a winner of Fast Company’s 2025 ...

A circulating tumor DNA (ctDNA) blood test demonstrated high sensitivity and specificity for colorectal cancer (CRC) detection in a large average-risk population, study finds.

Such evidence can show up in a person’s blood three-and-a-half years before their cancer would be otherwise diagnosed ...